Twitter LinkedIn
    Tuesday, May 24
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Acquisitions»Healthcare Giant Centene to Acquire Magellan Health for USD 2.2bn; 15% Premium
    Acquisitions

    Healthcare Giant Centene to Acquire Magellan Health for USD 2.2bn; 15% Premium

    January 4, 2021Updated:January 14, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    The acquisition will enable Centene to establish one of the nation’s largest behavioral health platforms across 41 million unique members.

    The Transaction:

    Centene Corp, St. Louis, Missouri-based healthcare insurer, announced today to acquire Magellan Health Inc, for an enterprise value of USD 2.2bn.

    Centene has agreed to pay USD 95 per share in cash to Magellan’s shareholders, representing c. 15% premium to Magellan’s last closing price.

    The combination brings together the companies’ complementary capabilities in behavioral health, specialty healthcare, and pharmacy management.

    The transaction, expected to complete in 2H 2021, is unanimously approved by the Boards of Directors of both companies. Affiliates of Starboard Value LP, which owns approximately 9.4% of Magellan, have agreed to vote in favor of the transaction.

    The CEO of Magellan, Ken Fasola, and other management executives have agreed to join Centene to provide continuity to Magellan Health’s strategy and leadership.

    NYSE-listed, Centene has a current market value of USD 34.8bn, while Nasdaq-listed Magellan has a current market value of USD 2.1bn.

    Centene has been active in acquiring healthcare-related businesses. Last month, it had completed the acquisition of PANTHERx Rare Pharmacy, a pharmacy chain in the U.S. specializing in orphan drugs and rare diseases, and Apixio, a healthcare analytics company offering Artificial Intelligence (AI) technology solutions, according to AnalyzeMarkets Global Deals Data.

    In January last year, Centene had completed the acquisition of WellCare Health Plans Inc. for USD 17bn in a take-private transaction.

    Advisors:

    Allen & Company LLC, J.P. Morgan Securities LLC, and Barclays are serving as financial advisors to Centene, and Skadden, Arps, Slate, Meagher & Flom LLP is serving as its legal counsel.

    Goldman Sachs & Co. LLC and Guggenheim Securities, LLC are serving as financial advisors to Magellan Health, and Weil, Gotshal & Manges LLP is serving as its legal counsel.

    Source: Analyze Markets ltd

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Acquisitions deals Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Vista Equity Partners Among the First Major U.S. Private Equity Firms to Advance Global ESG Strategy with Portfolio-Wide Participation in Climate Program

    May 23, 2022

    General Atlantic eyeing $2 bn investment in India, SE Asia

    May 23, 2022

    Software firm SpotOn valued at $3.6bn after Dragoneer-led funding round

    May 23, 2022

    Blackstone Credit Acquires 49% Interest in U.S. East Coast LNG Infrastructure Asset

    May 23, 2022

    Comments are closed.

    Other Articles

    VAM Funds partners with Foresight Capital Management to launch VAM Global Infrastructure Fund

    June 2, 2021

    The Fight Over JCPenney’s Real Estate Foreshadows the Fate of Malls

    December 31, 2020

    Brookfield seeks to take real estate arm private in $5.9bn deal

    January 5, 2021

    Clearlake Capital and TA Associates acquire Kofax from Thoma Bravo

    April 27, 2022

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?